Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Mice without the enzyme HSD17B3 still produce normal testosterone, suggesting they have different ways to make it compared to humans.

SVF injections improve hair growth and reduce hair loss in people with androgenic alopecia.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

The inhibitor affects androgen metabolism but not ovarian function.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Setipiprant may reduce inflammation by blocking an enzyme called aldose reductase.

Finasteride almost fully depletes allopregnanolone in rat brains and enhances 20α-DHP, but doesn't change 3α-DHP levels.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Lower levels of certain brain chemicals are linked to worse PTSD symptoms in men.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

Using lidocaine before keloid injections makes the treatment more comfortable for patients.

A new gel containing minoxidil can treat hair loss effectively, potentially reducing side effects and improving treatment.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

Minocycline may cause hair loss by increasing DHT levels, but finasteride can help counteract this effect.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Adipose tissue shows promise for hair regrowth, but more research is needed to confirm best practices and effectiveness.

Fluoxetine's effectiveness as an antidepressant in mice depends on a specific protein activity and a 5-minute pretest.

The plant combination effectively repairs skin and delays aging.

A thorough diagnostic process and teamwork are crucial for managing complex hyperandrogenism in postmenopausal women.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Excess androgens may cause PCOS, not just be a symptom.

Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.

DHT in the human prostate is produced through multiple pathways, not just from testosterone.